Inflammatory hematological indicators from a complete blood count (CBC) have even been identified as potential prognostic factors for CVD mortality [43].Therefore, regulating and intervening in the activation of the NLRP3 inflammasome offers a new perspective for treating CVD-depression comorbidity (Figure 1). Here, NLRP3 is linked to depressive symptom measurement.